Aghajanian and Company Inc.

Private Company, Headquarters Location
806 Sharon Dr., Ste. 2-C, Cleveland, OH 44145, United States
(440)871-7817, (440)871-7786 fax,

Primary SIC: Specialty Cleaning Polishing, Primary NAICS: Polish and Other Sanitation Good Manufacturing
Description: Manufacturing: Specialty Cleaning Polishing

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Aghajanian and Company Inc., News and Information

Award-Winning EZ Brite Brands, Inc., 'Zero-Waste' Manufacturer, to Host Bioneers Cleveland Tour for 2nd Consecutive Year.
Biotech Week; 11/18/2009; 848 words; EZ Brite Brands, Inc., an award-winning, "zero-waste" company that develops and manufactures...also EZ Brite Brands, Inc.). "We are proud...plant tour," says Ed Aghajanian, president, EZ Brite Brands, Inc. "We're always happy...

CARPOD(R) Delivers Cargo-Carrying Solutions in Time for Summer.
PR Newswire; 6/8/2009; 800 words; ...carpodrack.com/. About Carpod Inc. Founded in 2007, Carpod Inc. is the innovative company behind CARPOD(R), the carrier...and magazines. Contact: Martin Aghajanian CEO/President, Carpod Inc. 818-395-8676 martin@carpodrack...

2009 Evolution of Manufacturing: 'Briter' days ahead
Smart Business Cleveland; 2/1/2009; 576 words; ...reading this story, Ed Aghajanian would probably like to...At EZ Brite Brands Inc., the Westlake manufacturer...safe materials, but the company has put the same expectation...tight economic times, Aghajanian has repeatedly asked...REACH: EZ Brite Brands Inc., (440) 871-7817...

BiPar Sciences Expands Clinical Development of BSI-201, A Novel PARP Inhibitor, With Phase 2 Trial in Uterine Cancer.
PR Newswire; 5/28/2008; 859 words; ...BiPar Sciences, Inc. today announced it has...PARP) inhibitor in the company's DNA repair portfolio...tolerated," said Carol Aghajanian, M.D., chief of the...Development of BiPar Sciences, Inc., +1-650-635...for BiPar Sciences, Inc. Web site: http...

BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer.
Health & Medicine Week; 5/19/2008; 766 words; BiPar Sciences, Inc. announced the expansion...a>). The company is evaluating BSI-201...cancer," said Carol Aghajanian, M.D., co- principal...sensitive to the drug." The company is currently conducting...Health, BiPar Sciences Inc. This article was prepared...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.